New China Life Insurance Company Ltd. (NCI) has announced adjustments to the membership of its board committees following the eleventh meeting of the ninth Board session held on 26 August 2026.
NCI’s directors elected Mr. HUANG Geng to join both the Strategy and ESG Committee as well as the Investment and Asset Liability Management Committee. These appointments—and those of incoming independent non-executive director Ms. Sau Fun CHEUNG—will become effective once regulatory authorities confirm their qualifications.
Post-adjustment, the committees are structured as follows: • Strategy and ESG Committee: six members chaired by Mr. YANG Yucheng, now including Mr. HUANG Geng. • Investment and Asset Liability Management Committee: six members led by Mr. MAO Sixue, with Mr. HUANG Geng and Ms. Sau Fun CHEUNG listed as members. • Audit and Related Party Transaction Control Committee: five members chaired by Mr. GUO Yongqing. • Nomination and Remuneration Committee: six members headed by Mr. XU Xu. • Risk Management and Consumer Rights Protection Committee: five members chaired by Ms. YANG Xue.
Until Ms. Sau Fun CHEUNG’s directorship is formally approved, current independent non-executive director Mr. MA Yiu Tim will continue to fulfill his duties.
As of 26 August 2026, NCI’s Board comprises Chairman and executive director Mr. YANG Yucheng, executive director Mr. GONG Xingfeng, four non-executive directors, and four independent non-executive directors.
Comments